The Mexico hemp CBD market size was valued at USD 47.1 million in 2019 and is expected to grow at a significant rate over the forecast period. Key factors attributing to the market growth are favorable government policies that contributed to the increasing adoption of hemp-derived products and the growing acceptance of cannabidiol (CBD) among the users due to its innumerable health benefits. Moreover, growing awareness about cannabidiol due to its non-psychoactive properties is anticipated to drive the market for hemp CBD over the forecast period.
In 2017, the Mexican government legalized the cultivation, production, and use of medical cannabis containing less than 1% tetrahydrocannabinol (THC). This distinctive law passed by the government gave freedom to people for using CBD products in daily life. Moreover, in November 2018, the government approved the import and sale of thirty-eight cannabis products which include food supplements, cosmetics, food items, and raw hemp oil. This approval made hemp-derived products easily accessible to the population.
Moreover, the usage of cannabidiol is growing at a significant rate in the country. Products such as oil, beverages, beauty and skincare products, gummies, capsules, and pet foods are preferred among people due to their health benefits. Also, cannabidiol is used extensively in the manufacturing of medical drugs due to a lack of psychoactive effects. Moreover, the legalization of these products has created opportunities for end-user industries to expand their market reach in Mexico.
Mexico is the second-largest market for personal care products in Latin America. Products with natural and organic ingredients are reporting high demand because of the strong need among consumers for using natural products. This, in turn, is creating a demand for cannabidiol-based skincare products as they possess anti-inflammatory, anti-aging, and antioxidant properties. Moreover, customers can easily access these products from online and retail stores. This high availability of products and growing demand for using chemical-free products is expected to drive sales of hemp-derived CBD during the forecast period.
However, the high cost of CBD products is obstructing market growth. The cost of cannabidiol is high and fluctuates from one company to another. Their prices are dependent on farming practices, quality, extraction process cost, laboratory testing cost, and various other factors. The extraction of cannabidiol from hemp is an expensive process, as currently, there are a limited number of processors available for extracting cannabidiol from hemp biomass. The shortage of processors is increasing the overall cost of products. Moreover, the import of CBD-based products from other countries also increases the overall price of these products.
Based on the distribution channel, the Mexico hemp CBD market is further segmented into B2B and B2C. The B2C channel is anticipated to dominate the market with a revenue of USD 25.0 million in 2019. The B2C channel mainly comprises pharmacies, online stores, and retail stores through which manufacturers are selling their products to consumers. In 2019, retail stores dominated the market for hemp CBD, whereas, the online store's segment is anticipated to grow at the fastest rate over the forecast period.
The retail stores provide CBD products such as personal care items, food items, and energy drinks without any prescription and at lucrative pricing. Also, the companies operating in the Mexico CBD space are more focused on launching their products via retail chains as a preferred distribution channel. On the other hand, online stores are expected to gain traction in the Mexico market for hemp CBD. This is owing to wider internet access, availability of a wide range of products from numerous producers, and rising per capita expenditure in Mexico.
Based on end-use, the market for hemp CBD is segmented into personal use, personal care and cosmetics, food and beverage, nutraceuticals, and others. The personal use segment is anticipated to dominate the market for hemp CBD with a revenue share of 53.1% in 2019. The growing usage of cannabidiol oil and tinctures in various personal care remedies to obtain its health benefits, and the easy availability of these products through retail or online channels have contributed greatly to their adoption.
On the other hand, the food and beverage segment is anticipated to grow at the fastest rate over the forecast period. Consumers refraining from consuming cannabidiol in its raw form, owing to its bitter taste and smell, tend to consume it in innovative forms such as gummies, baked food, lemonades, tea, and energy drinks. Also, the availability of these forms at affordable prices is attracting a greater population and is expected to drive the market for hemp CBD over the forecast period.
The market for hemp CBD consists of major players such as HempMeds (Medical Marijuana Inc.), Aurora Cannabis, CBD Life, Elixinol, and Joy Organics. These companies are focused on new product launches, increasing imports to meet the growing demand for cannabidiol in the country, and developing new partnerships with retail chains and pharmacies to strengthen their distribution network in the country. Moreover, an increase in the number of approvals granted by the Mexican government, supporting medical cannabis usage is further expected to drive the market for hemp CBD over the forecast period.
Attribute |
Details |
The base year for estimation |
2019 |
Forecast period |
2020 - 2025 |
Market representation |
Revenue in USD Million, Volume in Kilos, and CAGR from 2019 to 2025 |
Report coverage |
Revenue & volume forecast, regulatory scenario, growth factors, and trends |
15% free customization scope (equivalent to 5 analysts working days) |
If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization |
This report forecasts revenue growth in Mexico and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For this study, GVR has segmented the Mexico hemp CBD market report based on distribution channel and end use:
Distribution Channel Outlook (Volume, Kilos; Revenue, USD Million, 2014 - 2025)
B2B
B2C
Pharmacies
Online Store
Retail Stores
End-use Outlook (Volume, Kilos; Revenue, USD Million, 2014 - 2025)
Personal Use
Personal Care & Cosmetics
Skin Care
Others
Food & Beverages
Nutraceuticals
Others
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
Multiple therapeutic regimens are being followed across the globe in attempts to come up with a reliable treatment for Covid-19. One line of treatment includes the use of hydroxychloroquine, while a second treatment line focuses to use antiviral drugs used in the disease management of HIV. Both these approaches have surged demand from advanced antivirals and antimalarial drugs. This impacts the drug manufacturers as an off label indication for these drug classes has to be worked upon. At the moment, the WHO has not prescribed any of these approaches, neither they have commented if one is better than the other. The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.